Katherine Janeway, MD, MMSc, explains what precision oncology is, and how researchers are bridging gaps in precision treatment for osteosarcoma.

Medical oncologist and researcher Joelle Fenger, DVM, shares how this debilitating disease affects our canine friends and what new treatments are on the horizon.

Fernanda Arnaldez, MD, explains that small sample sets, disease complexity, and limited funding pose challenges in rare disease drug development, but the field is rapidly evolving, making her optimistic about the future.

OSI Grant Winner Daniel Vallera, PhD, explains a promising experimental osteosarcoma treatment intended to multiply the immune system’s “first responders” to combat osteosarcoma in dogs and humans.

James Morrow, MD, PhD, is working to understand why osteosarcoma spreads — and how to stop it.

This groundbreaker and world-renowned pediatric surgical oncologist is determined to change osteosarcoma outcomes.